Literature DB >> 20538595

Phosphorylation and ubiquitination of degron proximal residues are essential for class II transactivator (CIITA) transactivation and major histocompatibility class II expression.

Kavita Purnanda Bhat1, Agnieszka Dorota Truax, Susanna Fletcher Greer.   

Abstract

Major histocompatibility (MHC) class II molecules are cell surface glycoproteins that present extracellular antigens to CD4(+) T cells and are essential for initiation of the adaptive immune response. MHC class II expression requires recruitment of a master regulator, the class II transactivator (CIITA), to the MHC class II promoter. Post-translational modifications to CIITA play important roles in modulating CIITA mediated transcription of various genes in different cell types. We have previously linked regulation of CIITA to the Ubiquitin Proteasome System (UPS), and we and others have demonstrated that mono-ubiquitination of CIITA dramatically increases its transactivity whereas poly-ubiquitination leads to CIITA degradation. Here we identify three degron proximal lysine residues, Lys-315, Lys-330, and Lys-333, and a phosphorylation site, Ser-280, located within the CIITA degron, that regulate CIITA ubiquitination, stability, and MHC class II expression. Together, these findings contribute to the developing post-translational modification code for CIITA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20538595      PMCID: PMC2923977          DOI: 10.1074/jbc.M110.127746

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.

Authors:  K Masternak; A Muhlethaler-Mottet; J Villard; M Zufferey; V Steimle; W Reith
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

2.  Downregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines.

Authors:  G Li; J A Harton; X Zhu; J P Ting
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

3.  The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models.

Authors:  A D Medhurst; D C Harrison; S J Read; C A Campbell; M J Robbins; M N Pangalos
Journal:  J Neurosci Methods       Date:  2000-05-15       Impact factor: 2.390

4.  Sequential modifications in class II transactivator isoform 1 induced by lipopolysaccharide stimulate major histocompatibility complex class II transcription in macrophages.

Authors:  Gorazd Drozina; Jiri Kohoutek; Tadashi Nishiya; B Matija Peterlin
Journal:  J Biol Chem       Date:  2006-11-09       Impact factor: 5.157

Review 5.  Epigenetic silencing of MHC2TA transcription in cancer.

Authors:  Tjadine M Holling; Marja C J A van Eggermond; Martine J Jager; Peter J van den Elsen
Journal:  Biochem Pharmacol       Date:  2006-08-01       Impact factor: 5.858

6.  Cutting edge: the class II transactivator prevents activation-induced cell death by inhibiting Fas ligand gene expression.

Authors:  T S Gourley; C H Chang
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

7.  Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes.

Authors:  C Spilianakis; J Papamatheakis; A Kretsovali
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

8.  MHC class II transactivator inhibits IL-4 gene transcription by competing with NF-AT to bind the coactivator CREB binding protein (CBP)/p300.

Authors:  T J Sisk; T Gourley; S Roys; C H Chang
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

Review 9.  Regulating the activity of class II transactivator by posttranslational modifications: exploring the possibilities.

Authors:  Xiaoyan Wu; Xiaocen Kong; Larry Luchsinger; Barbara D Smith; Yong Xu
Journal:  Mol Cell Biol       Date:  2009-08-31       Impact factor: 4.272

10.  A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation.

Authors:  Hiroshi Okabe; Sang-Hyun Lee; Janyaporn Phuchareon; Donna G Albertson; Frank McCormick; Osamu Tetsu
Journal:  PLoS One       Date:  2006-12-27       Impact factor: 3.240

View more
  13 in total

Review 1.  Towards a systems understanding of MHC class I and MHC class II antigen presentation.

Authors:  Jacques Neefjes; Marlieke L M Jongsma; Petra Paul; Oddmund Bakke
Journal:  Nat Rev Immunol       Date:  2011-11-11       Impact factor: 53.106

Review 2.  Regulation of major histocompatibility complex class II genes.

Authors:  Nancy M Choi; Parimal Majumder; Jeremy M Boss
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

3.  A mental retardation-linked nonsense mutation in cereblon is rescued by proteasome inhibition.

Authors:  Guoqiang Xu; Xiaogang Jiang; Samie R Jaffrey
Journal:  J Biol Chem       Date:  2013-08-27       Impact factor: 5.157

Review 4.  Proteomic identification of protein ubiquitination events.

Authors:  Guoqiang Xu; Samie R Jaffrey
Journal:  Biotechnol Genet Eng Rev       Date:  2013

Review 5.  Structural aspects of the MHC expression control system.

Authors:  Grady Nash; Bhaskar Paidimuddala; Liman Zhang
Journal:  Biophys Chem       Date:  2022-02-15       Impact factor: 2.352

6.  Development of potent class II transactivator gene delivery systems capable of inducing de novo MHC II expression in human cells, in vitro and ex vivo.

Authors:  M L Palma; P Duangkhae; B Douradinha; I F T Viana; P O Rigato; R Dhalia; R B Mailliard; S M Barratt-Boyes; E J M Nascimento; T M Oshiro; A J da Silva Duarte; E T A Marques
Journal:  Gene Ther       Date:  2017-04-17       Impact factor: 4.184

7.  The ubiquitination of the influenza A virus PB1-F2 protein is crucial for its biological function.

Authors:  Ivan Košík; Margaréta Práznovská; Martina Košíková; Zuzana Bobišová; Jaroslav Hollý; Eva Varečková; František Kostolanský; Gustáv Russ
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

8.  The class II transactivator (CIITA) is regulated by post-translational modification cross-talk between ERK1/2 phosphorylation, mono-ubiquitination and Lys63 ubiquitination.

Authors:  Julie E Morgan; Ronald L Shanderson; Nathaniel H Boyd; Ercan Cacan; Susanna F Greer
Journal:  Biosci Rep       Date:  2015-06-19       Impact factor: 3.840

9.  Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III.

Authors:  Yves B Beaulieu; Jorge A Leon Machado; Sylvain Ethier; Luc Gaudreau; Viktor Steimle
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

10.  Expression regulation of major histocompatibility complex class I and class II encoding genes.

Authors:  Peter J van den Elsen
Journal:  Front Immunol       Date:  2011-10-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.